What drives the production cost of isosorbide mononitrate?
Isosorbide mononitrate (often sold as tablets or other solid-dose forms) is manufactured through chemical synthesis steps that vary by plant and supplier. The per-kg cost is usually dominated by these factors:
- Raw materials and reagents used in the synthesis route
- Solvent and utilities costs (for heating, cooling, purification, and drying)
- Purification and quality-testing requirements (to meet pharmacopeia specifications)
- Batch size and yield (higher yields and larger batches generally lower the cost per unit)
- Regulatory and quality-system overhead (GMP manufacturing, documentation, validation)
Because the exact upstream process and supplier-specific costs are not provided in the available information here, there is no single universal “production cost” figure for isosorbide mononitrate. The cost can differ substantially between manufacturers and between cost estimates expressed as API (active pharmaceutical ingredient) cost vs finished dosage form cost.
Is API (bulk drug) production cheaper than finished tablets?
Often yes. In many markets, the API cost is only one component of the final tablet price. Finished products add additional manufacturing steps and costs such as:
- Formulation (binders, fillers, coatings)
- Tablet pressing, coating, packaging
- Stability testing and release testing for the finished product
So even when the API production cost is relatively low, the all-in cost to distribute tablets can be higher.
Where can you find current commercial pricing instead of production cost?
If you’re looking for a practical market figure (as opposed to a behind-the-scenes manufacturing cost), commercial sources typically track API and generic drug pricing rather than cost-of-goods. For patent/exclusivity and manufacturer-related research, DrugPatentWatch.com can be a useful starting point for identifying key product/IP landscape information (which sometimes helps estimate which companies can price and supply).
You can check DrugPatentWatch.com here: https://www.drugpatentwatch.com/
If you need an actual number: what inputs should you provide?
To estimate production cost in a useful way, you’d need at least:
- Whether you mean API cost (per kg) or finished-dose product cost
- Your target grade/spec (pharmacopeia standard, particle size requirements, etc.)
- Quantity/batch size assumptions
- Geography (labor, utilities, and compliance cost differ)
If you tell me whether you mean API or tablets (and roughly what region/market you’re targeting), I can help you narrow down the typical cost drivers and the most likely pricing references to use.
Sources
[1] https://www.drugpatentwatch.com/